BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19632872)

  • 1. Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India.
    Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Yephthomi T; Pradeep A; Saghayam S; Flanigan T; Mayer KH; Solomon S
    Int J Infect Dis; 2010 Feb; 14(2):e127-31. PubMed ID: 19632872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
    Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
    Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
    Mzileni MO; Longo-Mbenza B; Chephe TJ
    Pol Arch Med Wewn; 2008 Oct; 118(10):548-54. PubMed ID: 19112815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
    Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
    Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
    Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Anglaret X; Yazdanpanah Y; Wang B; Toure S; Seage GR; N'Dri-Yoman T; Walensky RP; Dakoury-Dogbo N; Goldie SJ; Messou E; Weinstein MC; Deuffic-Burban S; Salamon R; Freedberg KA
    S Afr Med J; 2006 Jun; 96(6):526-9. PubMed ID: 16841136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P;
    Scand J Infect Dis; 2005; 37(6-7):482-7. PubMed ID: 16089023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India.
    Sharma SK; Kadhiravan T; Banga A; Goyal T; Bhatia I; Saha PK
    BMC Infect Dis; 2004 Nov; 4():52. PubMed ID: 15555069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.
    Bonnet F; Morlat P; Chêne G; Mercié P; Neau D; Chossat I; Decoin M; Djossou F; Beylot J; Dabis F;
    HIV Med; 2002 Jul; 3(3):195-9. PubMed ID: 12139658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King county adult/adolescent spectrum of HIV-related diseases project.
    Uhlenkott MC; Buskin SE; Kahle EM; Barash E; Aboulafia DM
    Am J Med Sci; 2008 Sep; 336(3):217-23. PubMed ID: 18794615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
    Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
    AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
    Wolff AJ; O'Donnell AE
    Chest; 2001 Dec; 120(6):1888-93. PubMed ID: 11742918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-based differences in treatment and outcome among HIV patients in South India.
    Kumarasamy N; Venkatesh KK; Cecelia AJ; Devaleenol B; Saghayam S; Yepthomi T; Balakrishnan P; Flanigan T; Solomon S; Mayer KH
    J Womens Health (Larchmt); 2008 Nov; 17(9):1471-5. PubMed ID: 18954236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
    Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
    HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.
    Chow A; Tey J; Win MK; Leo YS
    Ann Acad Med Singap; 2012 Dec; 41(12):563-70. PubMed ID: 23303113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.